Panax ginseng C.A. Meyer’in Etkinliği ve Güvenliliği Üzerine Derleme

Year 2018, Volume: 38 Issue: 1, 11 - 23, 15.01.2018

İşıl Nur Apaydın Sevtap Aydın

Abstract

Panax ginseng (Panax ginseng, C.A. Meyer) (P. ginseng) yüzyıllar boyunca özellikle Doğu Asya kültürlerinde geleneksel bitkisel ilaç olarak kullanılmaktadır. Yapılan araştırmalar P. ginseng’in öğrenme kabiliyetini geliştirdiğini, antidepresan etkisinin bulunduğunu, nörolojik fonksiyonları düzelttiğini ve kan dolaşımını düzenlediğini göstermektedir. Ayrıca karaciğerin korunması ve iyileşmesi üzerine etkili olduğu, erektil disfonksiyonunu düzelttiği, çeşitli kanser hücre gelişmesini inhibe edebildiği bildirilmektedir. Günümüze kadar P. ginseng’in farmakolojik özellikleri üzerine çok sayıda klinik araştırmalar yapılmış olmasında rağmen, birçok sistematik derleme bu ile ilgili verilerin hala yetersiz olduğunu ve klinik etkinlik için güçlü kanıtların bulunamadığını ortaya koymaktadır. P. ginseng’in uzun süredir kullanılması ve klinik çalışma sonuçları bitkinin ciddi bir güvenlilik kaygısı taşımadığını göstermektedir, ancak hipersensitivite reaksiyonları, mide-bağırsak problemleri ve uykusuzluk yapabileceği, ancak bu belirtiler hafif ve geri dönüşümlü etkilerdir. Klinik araştırmalarda etkileşimlerle ilgili olgu sunumlarının doğruluğu kanıtlanamamasına rağmen ilaç-bitki etkileşmeleri açısında dikkat edilmelidir. Yeterli veri olmadığı için hamilelik ve emzirme döneminde ve pediatrik gruplarda kullanılması önerilmemektedir. Bu derleme kapsamında P.ginseng’in geleneksel kullanımı, farmakokinetiği, farmakolojik etkileri, toksisitesi ve güvenli kullanımı tartışılmıştır.

Keywords

Panax ginseng, ginsenozitler, toksisite, güvenlilik, insan sağlığı

Panax ginseng C.A. Meyer’in Etkinliği ve Güvenliliği Üzerine Derleme

Abstract

Panax ginseng (Panax ginseng, C.A.Meyer) (P. ginseng) have been used as traditional herbal medicine for centuries, especially in Eastern Asian cultures. The research shows that P. ginseng develops learning ability, has antidepressant effect, ameliorates neurological functions, and regulates blood circulation. Moreover, it has been reported to be effective on liver protection and healing, to improve erectile dysfunction, to inhibit cell progression in various cancer cells. Despite the fact that numerous clinical studies have been conducted on the pharmacological properties of P. ginseng until today, several systematic reviews have revealed that related data is still inconclusive and strong evidence for clinical efficacy cannot be deduced. Due to the long-standing use of P. ginseng and the outcome of clinical trials, it seems not to have serious safety concerns, however it has been reported that it may couse hypersensitivity reactions, gastrointestiral disordes and insomnia. However, these symptoms are mild and reversible. Despite case reports on interactions can not be verified in clinical trials, drug-herbal interactions should be considered. Since there is not enough data, it is not recommended to use during pregnancy and lactation and in pediatric groups. In this review, the traditional use, the pharmacokinetics and pharmacological effects, toxicity and safety use of P. ginseng has been discussed.

Keywords

Panax ginseng, ginsenosides, toxicity, safety, human health

References

• 1. Bensky D, Clavey S, Stöger E, Gamble A: Chinese Herbal Medicine Materia Medica. 3. Baskı. Eastland Press: Seattle, USA, 2004.
• 2. EMA, European Medicines Agency: Assesment report on Panax ginseng C.A. Meyer, radix. EMA/HMPC/321232/2012. 2013 March 12. Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Herbal_-_HMPC_assessment_report/2013/04/ WC500142080.pdf.
• 3. Baytop A: Farmasötik Botanik Ders Kitabı. Dialypetalae: İ.Ü. Basımevi ve Film Merkezi; İstanbul, Türkiye, 1991, pp. 219.
• 4. Choi K: Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer, Acta Pharmacologica Sinica 2008, 29(9):1109-1118.
• 5. Ru W, Wang D, Xu Y, He X, Sun YE, Qian L, Zhou X, Qin Y: Chemical constituents and bioactivities of Panax ginseng (C.A. Mey.). Drug Discoveries & Therapeutics 2015, 9(1):23-32.
• 6. Ortaç M: Erektil Disfonksiyon Tedavisinde Fitoterapi. Androloji Bülteni 2016, 18(64):20-23.
• 7. Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, Yoo YB, Ko YC, Jun WT, Park HJ: Possible Role of Ginsenoside Rb1 on Regulation of Rat Liver Triglycerides. Biological & Pharmaceutical Bulletin 2002, 25(4):457-460.
• 8. Sezgin C. Kanserde Bitkilerle Tedavide Örnek Uygulamalar. In: Çekin MD, Altuncan F, Yakut A, Tınmaz MZ (eds). Bitkilerle Tedavi Sempozyumu. Anka; İstanbul. 2011: pp 73-78.
• 9. Yamada N, Araki H, Yoshimura H: Identification of antidepressant- like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors. Psychopharmacology 2011, 216(4):589-599.
• 10. Ye R, Kong X, Yang Q, Zhang Y, Han J, Zhao G: Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology 2011, 61(4), 815-824.
• 11. Kitts DD, Hu C: Efficacy and safety of ginseng. Public Health Nutrition 2000, 3(4A):473-485.
• 12. Tanker N, Koyuncu M, Coşkun M. Farmasötik Botanik Ders Kitabı. “Spermatophyta”: Ankara. 1993: pp. 350.
• 13. Seely D, Dugoua J, Perri D, Mills E, Koren G: Safety and Efficacy of Panax Ginseng During Pregnancy and Lactation. The Canadian Journal of Clinical Pharmacology 2008, 15(1):87-94.
• 14. Lee SM, Bae B, Park H, Ahn N, Cho B, Cho YL, Kwak YS: Characterization of Korean Red Ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition. Journal of Ginseng Research 2015, 39(4):384-391.
• 15. Wan D, Jiao L, Yang H, Liu S: Structural characterization and immunological activities of the water-soluble oligosaccharides isolated from the Panax ginseng roots. Planta 2012, 235(6):1289-1297.
• 16. Liu JH, Lee CS, Leung KM, Yan ZK, Shen BH, Zhao ZZ, Jiang ZH: Quantification of Two Polyacetylenes in Radix Ginseng and Roots of Related Panax Species Using a Gas Chromatography-Mass Spectrometric Method. Journal of Agricultural and Food Chemistry 2007, 55(22):8830-8835.
• 17. Quian ZM, Lu J, Gao QP, Li SP: Rapid method for simultaneous determination of flavonoid, saponins and polyacetylenes in Folium Ginseng and Radix Ginseng by pressurized liquid extraction and high-performance liquid chromatography coupled with diode array detection and mass spectrometry, Journal of Chromatography. A 2009, 1216(18):3825-3830.
• 18. Washida D, Kitanaka S: Determination of Polyacetylenes and Ginsenosides in Panax Species Using High Performance Liquid Chromatography. Chemical & Pharmaceutical Bulletin 2003, 51(11):1314-1317.
• 19. Han BH, Park MH, Han YN, Woo LK: Alkaloidal components of Panax ginseng. Archives of Pharmacal Research 1986, 9(1):21-23.
• 20. Han YN, Ryu SY, Han BH, Woo LK: Spinacine from Panax ginseng. Archives of Pharmacal Research 1987, 10(4):258-259.
• 21. Park JD, Kim MW, Yoo SJ, Wee JJ: Chemical studies on the ether-soluble alkaloidal fraction of Panax ginseng. Isolation of 1-carbobutoxy- β-carboline and 1-carbomethoxy-β-carboline. Archives of Pharmacal Research 1987, 10:197-199.
• 22. Park JD, Kim MW, Yoo SJ, Wee JJ: A thiazole and two β-carboline constitutents from Panax ginseng. Archives of Pharmacal Research 1988, 11(1):52-55.
• 23. Han BH, Park MH, Han YN: Isolation of isomaltol-α-d-glucopyranoside1 and ketopropyl-α-d-glucopyranoside2 from Korean red ginseng. Archives of Pharmacal Research 1985, 8(4): 257-260.
• 24. Matsuura H, Hirao Y, Yoshida S, Kunihiro K, Fuwa T, Kasai R, Tanaka O: Study of red ginseng: New glucosides and a note on the occurence of rnaltol. Chemical & Pharmaceutical Bulletin 1984, 32(11):4674.
• 25. Han BH, Park MH, Woo LK, Woo WS, Han YN: Studies on antioxidant components of Korean ginseng. Korean Journal of Biochemistry 1979, 12(1): 33-40.
• 26. Han BH, Park MH, Han YN: Studies on the antioxidant components of Korean ginseng (III). Archives of Pharmacal Research 1981, 4(1):53-58.
• 27. Huh BH, Lee IR, Han BH: Lingans from Korean red ginseng, Archives of Pharmacal Research 1990, 13(3):278-281.
• 28. Chan P, Peckham JC, Malarkey DE, Kissling GE, Travlos GS: Two- Year Toxicity and Carcinogenicity Studies of Panax ginseng in Fischer 344 Rats and B6C3F1 Mice. National Institute of Environmental Health Sciences Research Triangle Park 2011, 39(4):779-788.
• 29. Bacanlı M, Başaran N,Başaran AA: İlaç-bitkisel ilaç kullanımının toksikolojik sonuçları. Türkiye Klinikleri Journal of Pharmacy Sciences 2012, 1(2):83-94.
• 30. Ernst E: The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto and Kava. Annals of Internal Medicine 2002, 136(1):42-53.
• 31. Izzo AA, Carlo GD, Borreli F, Ernst E: Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. International Journal of Cardiology 2005, 98(1):1-14.
• 32. Zhao J, Su C, Yang C, Liu M, Tang L, Su W, Liu Z: Determination of ginsenosides Rb1, Rb2, and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2012, 64-65:94-97.
• 33 Sun D, Wang B, Shi M, Zhang YX, Zhou LF, Liu ZR, Wu ZL, Jiang W, Han JL, Xiong LZ, Zhao G: Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 2012, 19(3-4):369-373.
• 34. Xia C, Wang G, Sun J, Hao H, Xiong Y, Gu S, Shang L, Zheng C: Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of “Shenmai” injection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008, 862(1-2):72-78.
• 35. Yu K, Ma Y, Shao Q, Qu H, Cheng Y: Simultaneously determination of five ginsenosides in rabbit plasma using solid-phase extraction and HPLC/MS technique after intravenous administration of “Shenmai” injection. Journal of Pharmaceutical and Biomedical Analysis 2007, 44(2):532-539.
• 36. Zhou QL, Zhu DN, Yang YF, Xu W, Yang XW: Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng. Journal of Pharmaceutical and Biomedical Analysis 2017, 137:1-12.
• 37. Zhou D, Tong L, Wan M, Wang G, Ye Z, Wang Z, Lin R: An LC-MS method for simultaneous determination of nine ginsenosides in rat plasma and its application in pharmacokinetic study. Biomedical Chromatography : BMC 2011, 25(6):720-726.
• 38. Li L, Chen X, Li D, Zhong D: Identification of 20(S)-Protopanaxadiol Metabolites in Human Liver Microsomes and Human Hepatocytes. Drug Metabolism and Pharmacokinetics 2011a, 39(3):472-483.
• 39. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Medica 1996, 62(5):453-457.
• 40. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M: Degradation of ginsenosides in humans after oral administration. Drug Metabolism and Disposition : The Biological Fate of Chemicals 2003, 31(8):1065-1071.
• 41. Kennedy DO, Scholey AB, Drewery L, Marsh VR, Moore B, Ashton H: Electroencephalograph effects of single doses of Ginkgo biloba and Panax ginseng in healthy young volunteers. Pharmacology, Biochemistry, and Behavior 2003, 75(3):701-709.
• 42 Scholey AB, Kennedy DO: Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Human Psychopharmacology 2002, 17(1):35-44.
• 43. Hao K, Gong P, Sun SQ, Hao HP, Wang GJ, Dai Y, Liang Y, Xie L, Li FY. Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice. European Journal of Pharmacology 2011, 659(1):15-25.
• 44. Liu L, Hoang-Gia T, Wu H, Lee MR, Gu L, Wang C, Yun BS, Wang Q, Ye S, Sung CK: Ginsenoside Rb1 improves spatial learning and memory by regulation of cell genesis in the hippocampal subregions of rats. Brain Research 2011, 1382:147-154.
• 45. Li Y, Tang J, Khatibi NH, Zhu M, Chen D, Tu L, Chen L, Wang S: Treatment with Ginsenoside Rb1, A Component of Panax Ginseng Provides Neuroprotection in Rats Subjected to Subarachnoid Hemorrhage- Induced Brain Injury. Acta Neurochirurgica. Supplement 2011, 110(Pt2):75-79.
• 46. Wang LCH, Lee TF: Effect of Ginseng Saponins on Cold Tolerance in Young and Elderly Rats. Planta Medica 2000, 66(2):144-147.
• 47. Etou H, Sakata T, Fujimoto K, Terada K, Yoshimatsu H, Ookuma K, Hayashi T, Arichi S. [Ginsenoside-Rb1 as a suppressor in central modulation of feeding in the rat]. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 1988, 91(1):9-15.
• 48. Li L, Liu J, Yan X, Qin K, Shi M, Lin T, Zhu Y, Kang T, Zhao G: Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. Journal of Ethnopharmacology 2011, 138(1):135-141.
• 49. Xu C, Teng J, Chen W, Ge Q, Yang Z, Yu C, Yang Z, Jia W: 20(S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests. Progress in Neuro-psychopharmacology & Biological Psychiatry 2010, 34(8):1402-1411.
• 50. Rhee MY, Kim YS, Bae JH, Na DY, Kim YK, Lee MM, Kim HY: Effect of Korean Red Ginseng on Arterial Stiffness in Subjects with Hypertension. The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy 2011, 17(1):45-49.
• 51. Engels HJ, Fahlman MM, Wirth JC: Effects of ginseng on secretory IgA, performance, and recovery from interval exercise. Medicine & Science in Sports & Exercise 2003, 35(4):690-696.
• 52. Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM: Protective effect of ginsenoside Rb1 against myocardial ischemia/ reperfusion injury in streptozotocin-induced diabetic rats. Molecular Biology Reports 2011, 38(7):4327-4335.
• 53. Wang Z, Li M, Wu WK, Tan HM, Geng DF: Ginsenoside Rb1 Preconditioning Protects Against Myocardial Infarction After Regional Ischemia and Reperfusion by Activation Phosphatidylinositol- 3-kinase Signal Transduction. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy 2008, 22(6):443-452.
• 54. Li J, Xie ZZ, Tang YB, Zhou JG, Guan YY: Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. European Journal of Pharmacology 2011, 652(1-3):104-110.
• 55. Deng J, Wang YW, Chen WM, Wu Q, Huang XN: Role of nitric oxide in ginsenoside rg1-ınduced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biological and Pharmaceutical Bulletin 2010, 33(4): 631-635.
• 56. Han B, Meng Q, Li Q, Zhang J, Bi Y, Jiang N: Effect of 20(S)-protopanaxatriol and its epimeric derivatives on myocardial injury induced by isoproterenol. Arzneimittelforschung 2011, 61(3):148-152.
• 57. Yokozawa T, Kobayashi T, Oura H, Kawashima Y: Studies on the Mechanism of the Hypoglycemic Activity of Ginsenoside-Rb2 in Streptozotocin-Diabetic Rats. Chemical & Pharmaceutical Bulletin 1985, 33(2):869-872.
• 58. Cho WCS, Chung WS, Lee SKW, Leung AWN, Cheng CHK, Yue KKM: Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. European Journal of Pharmacology 2006, 550(1-3):173- 179.
• 59. Liu Z, Wang LJ, Li X, Hu JN, Chen Y, Ruan CC, Sun GZ: Hypoglycemic Effects of Malonyl-ginsenosides Extracted from the Roots of Panax ginseng on Streptozotocin-induced Diabetic Mice. Phytotherapy Research : PTR 2009, 23(10):1426-1430.
• 60. Ma SW, Benzie IF, Chu TT, Fok BS, Tomlinson B, Critchley LA: Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trail. Diabetes, Obesity & Metabolism 2008, 10(11):1125-1127.
• 61. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A: Korean red ginseng ( Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD 2008, 18(1):46-56.
• 62. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49(6):822-30.
• 63. de Andrade E, de Mesquita AA, Claro Jde A, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology, 2007, 9(2):241-244.
• 64. Hong B, Ji YH, Hong JH, Nam KY, Ahn TY: A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report. Journal of Urology 2002, 168(5):2070-2073.
• 65. Gün Ç, Demirci N: Menopozda bitkisel tedavi kullanımı. Arşiv Kaynak Tarama Dergisi 2015, 24(4): 520-530.
• 66. Scaglione F, Cogo R, Cocuzza C, Arcidiacono M, Beretta A: Immunomodulatory effects of Panax ginseng C.A. Meyer (G115) on alveolar macrophages from patients suffering with chronic bronchitis. International Journal of Immunotherapy and Cancer Research 1994, 10(1):21-24.
• 67. Saito H, Morita M, Takagi K: Pharmacological studies of Panax Ginseng Leaves. Japanese Journal of Pharmacology 1973, 23(1):43-56. (1973).
• 68. Jenny E: On the toxicity of the standardized ginseng extract G115® and pure ginsenosides. Un published report, 1982.
• 69. Berté F: Toxicological investigation of the standardized ginseng extract G115®. 1982 (unpublished report).
• 70. National Toxicology Program, 2011. NTP technical report on the toxicology and carcinogenesis studies of ginseng (CAS NO. 50647- 08-0) in F344/N rats and B6C3F1 mice. İnternet adresi: https://ntp. niehs.nih.gov/ntp/htdocs/lt_rpts/tr567.pdf (Erişim tarihi: 1/05/2017). [Website]
• 71. Stevens KR, Cox GE: Effects of feeding Ginseng Extract G115 to purebred Beagle dogs for 90 days. 1978.
• 72. Timm A: Salmonella typhimurium reverse mutation assay with Stand. Ginseng Extract G115. Report, CCR Project 149905, 1989.
• 73. Trabucchi E: Teratological investigation of the standardized Ginseng Extract G115. Investigational Report, 1971.
• 74. Hess FG Jr., Parent RA, Cox GE, Stevens KR, Becci PJ. Reproduction study in rats of Ginseng Extract G115. Food and Chemical Toxicology 1982, 20(2):189-192.
• 75. Bressler R: Interactions between ginseng and prescription medications. Geriatrics 2005, 60(8):16-17.
• 76. Gruenwald J: PDR for Herbal Medicines (Aloe, Echinacea, Flax, Garlic, Ginkgo, Ginseng, Licorice, Senna, St John’s Wort). Medical Economics Company; Montvale, New Jersey, USA, 2000. pp 16-8, 261-4, 3135,327-9, 342-4, 346-9, 469-472, 684-7, 719-23.
• 77. Williamson E, Driver S, Baxter K: Stockley’s Herbal Medicines Interactions (GeneralConsiderations, Aloe vera, Echinacea, Flaxseed, Garlic, Ginkgo, Ginseng, Liquorice, Senna, St John’s wort, Valerian), Pharmaceutical Press; Londra, UK, 2009.
• 78. Jones BD, Runikis AM: Interaction of ginseng with phenelzine. Journal of Clinical Psychopharmacology 1987, 7(3):201-202.
• 79. Brazier NC, Levine MAH: Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. American Journal of Therapeutics 2003, 10(3):163-169.
• 80. Paik DJ, Lee CH: Review of cases of patient risk associated with ginseng abuse and misuse. Journal of Ginseng Research 2015, 39(2):89-93.
• 81. Aslan M, Orhan N: Diyabet tedavisinde kullanılan bitkisel ürünler ve gıda destekleri, Mised 2010, (23-24):27-38.
• 82. Lee JY, Jin HJ, Park JW, Jung SK, Jang JY, Park HS: A Case of Korean Ginseng-Induced Anaphylaxis Confirmed by Open Oral Challenge and Basophil Activation Test. Allergy, Asthma & Immunology Research 2012, 42(2):110-111.
• 83. Lee NH, Son CG: Systematic Review of Randomized Controlled Trials Evaluating the Efficacy and Safety of Ginseng. Journal of Acupuncture and Meridian Studies 2011, 4(2):85−97.
• 84. Anderson GD, Rosito G, Mohustsy MA, Elmer GW: Drug interaction potential of Soy extract and Panax Ginseng. Journal of Clinical Pharmacology 2003, 43(6):643-648.
• 85. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY: Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John’s wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005, 22(6):525-539.